FORUM Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- FORUM Pharmaceuticals's estimated annual revenue is currently $3.7M per year.
- FORUM Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- FORUM Pharmaceuticals has 24 Employees.
- FORUM Pharmaceuticals grew their employee count by 0% last year.
FORUM Pharmaceuticals's People
Name | Title | Email/Phone |
---|
FORUM Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 65 | 5% | N/A | N/A |
#10 | $16.1M | 104 | 9% | N/A | N/A |
What Is FORUM Pharmaceuticals?
FORUM Pharmaceuticals Inc. (“FORUM Pharmaceuticals†or “FORUMâ€) is dedicated to developing transformative medicines to restore the minds of people with serious brain disease, empowering them to preserve their identity, dignity and the essence of what makes us human. The Company’s diverse pipeline is focused on discovering and developing new treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provide improvement in cognitive and overall function. FORUM is privately owned and based in Waltham, Mass. For more information about FORUM, visit www.forumpharma.com.
keywords:N/AN/A
Total Funding
24
Number of Employees
$3.7M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.9M | 24 | -4% | N/A |
#2 | N/A | 24 | 0% | N/A |
#3 | $2.9M | 24 | 0% | $14.3M |
#4 | $1.7M | 24 | -29% | $30.4M |
#5 | $1.7M | 24 | -76% | N/A |